CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guangxi Wuzhou Zhongheng Group, Ltd. Company Snapshot
Guangxi Wuzhou Zhongheng Group, Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Wuzhou Zhongheng Group, Ltd. with three other companies in this sector in China: Jilin Aodong Medicine Industry (Group) Co., Ltd. (2018 sales of 3.32 billion Chinese Renmimbi [US$495.81 million] of which 95% was Pharmaceutical Manufacturing), Zhuzhou Qianjin Pharmaceutical Co., Ltd. (3.33 billion Chinese Renmimbi [US$496.44 million] ), and Guangdong Taiantang Pharmaceutical Co Ltd (3.31 billion Chinese Renmimbi [US$494.18 million] of which 70% was Medicine Wholesale & Retail).

Sales Analysis. During the year ended December of 2018, sales at Guangxi Wuzhou Zhongheng Group, Ltd. were 3.30 billion Chinese Renmimbi (US$491.98 million). This is an increase of 61.2% versus 2017, when the company's sales were 2.05 billion Chinese Renmimbi. This was the third consecutive year of growth at Guangxi Wuzhou Zhongheng Group, Ltd.. Sales of Pharmaceutical Segment saw an increase of 66.4% in 2018, from 1.90 billion Chinese Renmimbi to 3.15 billion Chinese Renmimbi. Not all segments of Guangxi Wuzhou Zhongheng Group, Ltd. experienced an increase in sales in 2018: sales of Real Estate fell 14.6% to 29.84 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guangxi Wuzhou Zhongheng Group, Ltd.
  Stock Performance Chart for Guangxi Wuzhou Zhongheng Group, Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 3.47
(Figures in Chinese Renmimbi)
1 Week 1.2%   13 Weeks 5.5%  
4 Weeks 29.0%   52 Weeks -8.9%  
 
Guangxi Wuzhou Zhongheng Group, Ltd. Key Data:
  Ticker: 600252 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 3,298,367,531
(Year Ending Jan 2019).
Employees: 2,434
  Currency: Chinese Renmimbi Market Cap: 12,058,621,800
  Fiscal Yr Ends: December Shares Outstanding: 3,475,107,147
  Share Type: A Gu Closely Held Shares: 902,651,076
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.